Newswise — In order to validate our observation that Sorafenib was the cause of the gross changes seen in the ileostomy, full thickness biopsies of the ileostomy were taken shortly after Sorafenib was discontinued. There was ulceration of small bowel mucosa and a lack of the expected granulation tissue response as demonstrated by prominent stromal cells and paucity of capillary proliferation fig. 1A, B, C. This was confirmed by the vimentin staining highlighting the prominence of stromal cells fig. 1C. The paucity of endothelial proliferation was illustrated by the lack of CD34 positive cells fig. 1D. These findings are unlike the usual appearances of granulation tissue involved in ulcer related repair and were postulated to be related to the antiangiogenesis effect of Sorafenib.

Fig 1. Histology of stoma: (4 images with captions)

Written byFCS Eng, MD, AM Easson, MD, E Szentgyorgyi, MD, and JJ Knox, MD, as part of Beyond the Abstract on UroToday.com. This initiative offers a method of publishing for the professional urology community. Authors are given an opportunity to expand on the circumstances, limitations etc... of their research by referencing the published abstract.

About UroTodayUroToday.com attracts more than 55,000 readers monthly. The website covers over 22 urology disease categories and provides the most in depth Urological conference reports available online. UroToday.com is the world leader in delivering a quality, global online publication providing accurate and timely education that is clinically relevant in the practice of Urology. All scientific content is developed by urologists committed to translating research into clinically relevant science, including all genitourinary cancers, pediatric and geriatric urological dysfunctions for urologists, medical oncologists, advanced nurse practitioners and other medical professionals.

Read Full Abstract:

http://www.urotoday.com/38/browse_categories/renal_cancer/sorafenib_and_surgical_complications_a_case_report_of_adverse_reaction_to_sorafenib_during_treatment_for_renal_cell_carcinoma__abstract.html

MEDIA CONTACT
Register for reporter access to contact details
CITATIONS

European Journal of Surgical Oncology